188 related articles for article (PubMed ID: 26206265)
21. In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?
Mathivet T; Mazot P; Vigny M
Cell Signal; 2007 Dec; 19(12):2434-43. PubMed ID: 17904822
[TBL] [Abstract][Full Text] [Related]
22. Binge-like ethanol drinking activates anaplastic lymphoma kinase signaling and increases the expression of STAT3 target genes in the mouse hippocampus and prefrontal cortex.
Hamada K; Ferguson LB; Mayfield RD; Krishnan HR; Maienschein-Cline M; Lasek AW
Genes Brain Behav; 2021 Feb; ():e12729. PubMed ID: 33641239
[TBL] [Abstract][Full Text] [Related]
23. Expression of the pleiotrophin-midkine axis in a sheep tooth socket model of bone healing.
Nobakht S; Milne TJ; Duncan WJ; Ram A; Tkatchenko T; Dong Z; Coates DE
J Periodontal Res; 2023 Feb; 58(1):109-121. PubMed ID: 36411509
[TBL] [Abstract][Full Text] [Related]
24. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
[TBL] [Abstract][Full Text] [Related]
25. New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.
Di Paolo D; Yang D; Pastorino F; Emionite L; Cilli M; Daga A; Destafanis E; Di Fiore A; Piaggio F; Brignole C; Xu X; Liang C; Gibbons J; Ponzoni M; Perri P
Oncotarget; 2015 Oct; 6(30):28774-89. PubMed ID: 26299615
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
Schönherr C; Ruuth K; Kamaraj S; Wang CL; Yang HL; Combaret V; Djos A; Martinsson T; Christensen JG; Palmer RH; Hallberg B
Oncogene; 2012 Dec; 31(50):5193-200. PubMed ID: 22286764
[TBL] [Abstract][Full Text] [Related]
27. Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma.
Emdal KB; Pedersen AK; Bekker-Jensen DB; Lundby A; Claeys S; De Preter K; Speleman F; Francavilla C; Olsen JV
Sci Signal; 2018 Nov; 11(557):. PubMed ID: 30459283
[TBL] [Abstract][Full Text] [Related]
28. Flotillin-1 regulates oncogenic signaling in neuroblastoma cells by regulating ALK membrane association.
Tomiyama A; Uekita T; Kamata R; Sasaki K; Takita J; Ohira M; Nakagawara A; Kitanaka C; Mori K; Yamaguchi H; Sakai R
Cancer Res; 2014 Jul; 74(14):3790-801. PubMed ID: 24830726
[TBL] [Abstract][Full Text] [Related]
29. ALK pERKs up MYCN in neuroblastoma.
Lindner S; Henssen A; Astrahantseff K; Schulte JH
Sci Signal; 2014 Oct; 7(349):pe27. PubMed ID: 25351246
[TBL] [Abstract][Full Text] [Related]
30. Partial deletion of the ALK gene in ALK-positive anaplastic large cell lymphoma.
Fukuhara S; Nomoto J; Kim SW; Taniguchi H; Miyagi Maeshima A; Tobinai K; Kobayashi Y
Hematol Oncol; 2018 Feb; 36(1):150-158. PubMed ID: 28665006
[TBL] [Abstract][Full Text] [Related]
31. Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells.
Schönherr C; Yang HL; Vigny M; Palmer RH; Hallberg B
Oncogene; 2010 May; 29(19):2817-30. PubMed ID: 20190816
[TBL] [Abstract][Full Text] [Related]
32. Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis.
Lopez-Delisle L; Pierre-Eugène C; Louis-Brennetot C; Surdez D; Raynal V; Baulande S; Boeva V; Grossetête-Lalami S; Combaret V; Peuchmaur M; Delattre O; Janoueix-Lerosey I
Oncogene; 2018 Mar; 37(11):1417-1429. PubMed ID: 29321660
[TBL] [Abstract][Full Text] [Related]
33. Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma.
Hiwatari M; Seki M; Matsuno R; Yoshida K; Nagasawa T; Sato-Otsubo A; Yamamoto S; Kato M; Watanabe K; Sekiguchi M; Miyano S; Ogawa S; Takita J
Oncogene; 2022 May; 41(20):2789-2797. PubMed ID: 35411036
[TBL] [Abstract][Full Text] [Related]
34. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death.
Zamo A; Chiarle R; Piva R; Howes J; Fan Y; Chilosi M; Levy DE; Inghirami G
Oncogene; 2002 Feb; 21(7):1038-47. PubMed ID: 11850821
[TBL] [Abstract][Full Text] [Related]
35. Neuronal leucine-rich repeat 1 negatively regulates anaplastic lymphoma kinase in neuroblastoma.
Satoh S; Takatori A; Ogura A; Kohashi K; Souzaki R; Kinoshita Y; Taguchi T; Hossain MS; Ohira M; Nakamura Y; Nakagawara A
Sci Rep; 2016 Sep; 6():32682. PubMed ID: 27604320
[TBL] [Abstract][Full Text] [Related]
36. Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK.
Murray PB; Lax I; Reshetnyak A; Ligon GF; Lillquist JS; Natoli EJ; Shi X; Folta-Stogniew E; Gunel M; Alvarado D; Schlessinger J
Sci Signal; 2015 Jan; 8(360):ra6. PubMed ID: 25605972
[TBL] [Abstract][Full Text] [Related]
37. Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma.
Okubo J; Takita J; Chen Y; Oki K; Nishimura R; Kato M; Sanada M; Hiwatari M; Hayashi Y; Igarashi T; Ogawa S
Oncogene; 2012 Nov; 31(44):4667-76. PubMed ID: 22249260
[TBL] [Abstract][Full Text] [Related]
38. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.
Deuel TF
Biochim Biophys Acta; 2013 Oct; 1834(10):2219-23. PubMed ID: 23777859
[TBL] [Abstract][Full Text] [Related]
39. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma.
Singh RR; Cho-Vega JH; Davuluri Y; Ma S; Kasbidi F; Milito C; Lennon PA; Drakos E; Medeiros LJ; Luthra R; Vega F
Cancer Res; 2009 Mar; 69(6):2550-8. PubMed ID: 19244133
[TBL] [Abstract][Full Text] [Related]
40. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
